![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
20
Siegfried Pharmachemikalien Minden Gmbh Minden De, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Selegiline hydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 1999-124 - Rev 04
This Chemical Type CEP, issued on December 15, 2015, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1260 associated with this CEP further emphasizes